Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
As the drug showed a weight loss effect during research, the company shifted the target to obesity
This compound is supplied strictly for laboratory research use
In Qsymia trials, patients on Qsymia tended to lose about 8% to 10% of their weight in 56 weeks (about 13 months)
As a class, peptide therapeutics offer high specificity, relatively low toxicity, and the ability to mimic endogenous biological pathways, advantages that are increasingly attractive in complex chronic diseases
SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis
US$ 23.68
US$ 26.64
US$ 22.79
US$ 27.79
US$ 28.11
US$ 29.17
